Suchergebnisse - "Cubillo, Antonio"

PubPharm (5)

1

Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer : a phase II study

enthalten in: Future oncology (London, England) | 2022

von Strickler, J. | Cubillo, A. | Liang, J. | +7

2

Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Hubner, R. | Cubillo, A. | Blanc, J. | +10

3

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

enthalten in: Oncotarget | 2017

von Toledo, R. | Cubillo, A. | Vega, E. | +11

4

Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy : a Q-TWiST analysis

enthalten in: British journal of cancer | 2017

von Pelzer, U. | Blanc, J. | Melisi, D. | +11

5

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1) : a global, randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2016

von Wang-Gillam, A. | Li, C. | Bodoky, G. | +79

CommentIn: Lancet. 2016 Feb 6;387(10018):507-8. - PMID 26616909

1
[1]